Page last updated: 2024-12-07
e 5324
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
E 5324: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 132377 |
| CHEMBL ID | 47095 |
| SCHEMBL ID | 692563 |
| MeSH ID | M0238320 |
Synonyms (16)
| Synonym |
|---|
| bdbm50047557 |
| 1-butyl-3-{2-[3-(5-ethyl-4-phenyl-imidazol-1-yl)-propoxy]-6-methyl-phenyl}-urea |
| 141799-76-0 |
| e-5324 |
| e 5324 |
| urea, n-butyl-n'-02-03-(((5-ethyl-4-phenyl-1h-imidazol-1-yl)propoxy)-6-methylphenyl)- |
| n-butyl-n'-(2-(3-(5-ethyl-4-phenyl-1h-imidazol-1-yl)propoxy)-6-methylphenyl)urea |
| urea, n-butyl-n'-(2-(3-(5-ethyl-4-phenyl-1h-imidazol-1-yl)propoxy)-6-methylphenyl)- |
| e5324 |
| CHEMBL47095 , |
| 1-butyl-3-[2-[3-(5-ethyl-4-phenylimidazol-1-yl)propoxy]-6-methylphenyl]urea |
| SCHEMBL692563 |
| DTXSID20161824 |
| HY-19183 |
| CS-0014924 |
| AKOS040741679 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (1)
Inhibition Measurements
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Acyl-CoA:cholesterol acyltransferase | Oryctolagus cuniculus (rabbit) | IC50 (µMol) | 0.0880 | 0.0060 | 0.9846 | 7.6000 | AID31205 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Bioassays (4)
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.37
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||